诺诚健华一季度营收3.81亿元,净利实现扭亏

北京商报
13 May

北京商报讯(记者丁宁)5月13日晚间,诺诚健华(688428)发布2025年第一季度报告。报告期内,公司实现营业收入3.81亿元,同比增长129.92%;归属净利润1796.76万元,实现盈利。  诺诚健华表示,公司营收大幅增长主要归功于核心产品奥布替尼的持续放量以及公司与Prolium达成授权许可获得的首付款。奥布替尼当季同比增长89.2%,达到3.1亿元,主要是源于奥布替尼三大适应症,尤其是...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10